Reviews Livalo


No reviews yet.

Livalo Drug Description
LIVALO
(pitavastatin) Tablet, Film Coated for Oral use
DRUG DESCRIPTION
LIVALO (pitavastatin) is an inhibitor of HMG-CoA reductase. It is a synthetic lipid-lowering agent for oral administration.
The empirical formula for pitavastatin is C50H46CaF2N2O8
and the molecular weight is 880.98. Pitavastatin is odorless and occurs as white
to pale-yellow powder. It is freely soluble in pyridine, chloroform, dilute
hydrochloric acid, and tetrahydrofuran, soluble in ethylene glycol, sparingly
soluble in octanol, slightly soluble in methanol, very slightly soluble in water
or ethanol, and practically insoluble in acetonitrile or diethyl ether. Pitavastatin
is hygroscopic and slightly unstable in light.
The chemical name for pitavastatin is (+)monocalcium bis{(3R, 5S, 6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate}.
The structural formula is:









Each film-coated tablet of LIVALO contains 1.045 mg, 2.09 mg, or 4.18 mg of pitavastatin calcium, which is equivalent to 1 mg, 2 mg, or 4 mg, respectively of free base and the following inactive ingredients: lactose monohydrate, low substituted hydroxypropylcellulose, hypromellose, magnesium aluminometasilicate, magnesium stearate, and film coating containing the following inactive ingredients: hypromellose, titanium dioxide, triethyl citrate, and colloidal anhydrous silica.Last reviewed on RxList: 9/15/2009




Livalo Drug Description
LIVALO
(pitavastatin) Tablet, Film Coated for Oral use
DRUG DESCRIPTION
LIVALO (pitavastatin) is an inhibitor of HMG-CoA reductase. It is a synthetic lipid-lowering agent for oral administration.
The empirical formula for pitavastatin is C50H46CaF2N2O8
and the molecular weight is 880.98. Pitavastatin is odorless and occurs as white
to pale-yellow powder. It is freely soluble in pyridine, chloroform, dilute
hydrochloric acid, and tetrahydrofuran, soluble in ethylene glycol, sparingly
soluble in octanol, slightly soluble in methanol, very slightly soluble in water
or ethanol, and practically insoluble in acetonitrile or diethyl ether. Pitavastatin
is hygroscopic and slightly unstable in light.
The chemical name for pitavastatin is (+)monocalcium bis{(3R, 5S, 6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate}.
The structural formula is:









Each film-coated tablet of LIVALO contains 1.045 mg, 2.09 mg, or 4.18 mg of pitavastatin calcium, which is equivalent to 1 mg, 2 mg, or 4 mg, respectively of free base and the following inactive ingredients: lactose monohydrate, low substituted hydroxypropylcellulose, hypromellose, magnesium aluminometasilicate, magnesium stearate, and film coating containing the following inactive ingredients: hypromellose, titanium dioxide, triethyl citrate, and colloidal anhydrous silica.Last reviewed on RxList: 9/15/2009




Livalo Drug Description
LIVALO
(pitavastatin) Tablet, Film Coated for Oral use
DRUG DESCRIPTION
LIVALO (pitavastatin) is an inhibitor of HMG-CoA reductase. It is a synthetic lipid-lowering agent for oral administration.
The empirical formula for pitavastatin is C50H46CaF2N2O8
and the molecular weight is 880.98. Pitavastatin is odorless and occurs as white
to pale-yellow powder. It is freely soluble in pyridine, chloroform, dilute
hydrochloric acid, and tetrahydrofuran, soluble in ethylene glycol, sparingly
soluble in octanol, slightly soluble in methanol, very slightly soluble in water
or ethanol, and practically insoluble in acetonitrile or diethyl ether. Pitavastatin
is hygroscopic and slightly unstable in light.
The chemical name for pitavastatin is (+)monocalcium bis{(3R, 5S, 6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate}.
The structural formula is:









Each film-coated tablet of LIVALO contains 1.045 mg, 2.09 mg, or 4.18 mg of pitavastatin calcium, which is equivalent to 1 mg, 2 mg, or 4 mg, respectively of free base and the following inactive ingredients: lactose monohydrate, low substituted hydroxypropylcellulose, hypromellose, magnesium aluminometasilicate, magnesium stearate, and film coating containing the following inactive ingredients: hypromellose, titanium dioxide, triethyl citrate, and colloidal anhydrous silica.Last reviewed on RxList: 9/15/2009




Livalo Drug Description
LIVALO
(pitavastatin) Tablet, Film Coated for Oral use
DRUG DESCRIPTION
LIVALO (pitavastatin) is an inhibitor of HMG-CoA reductase. It is a synthetic lipid-lowering agent for oral administration.
The empirical formula for pitavastatin is C50H46CaF2N2O8
and the molecular weight is 880.98. Pitavastatin is odorless and occurs as white
to pale-yellow powder. It is freely soluble in pyridine, chloroform, dilute
hydrochloric acid, and tetrahydrofuran, soluble in ethylene glycol, sparingly
soluble in octanol, slightly soluble in methanol, very slightly soluble in water
or ethanol, and practically insoluble in acetonitrile or diethyl ether. Pitavastatin
is hygroscopic and slightly unstable in light.
The chemical name for pitavastatin is (+)monocalcium bis{(3R, 5S, 6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate}.
The structural formula is:









Each film-coated tablet of LIVALO contains 1.045 mg, 2.09 mg, or 4.18 mg of pitavastatin calcium, which is equivalent to 1 mg, 2 mg, or 4 mg, respectively of free base and the following inactive ingredients: lactose monohydrate, low substituted hydroxypropylcellulose, hypromellose, magnesium aluminometasilicate, magnesium stearate, and film coating containing the following inactive ingredients: hypromellose, titanium dioxide, triethyl citrate, and colloidal anhydrous silica.Last reviewed on RxList: 9/15/2009




Livalo Drug Description
LIVALO
(pitavastatin) Tablet, Film Coated for Oral use
DRUG DESCRIPTION
LIVALO (pitavastatin) is an inhibitor of HMG-CoA reductase. It is a synthetic lipid-lowering agent for oral administration.
The empirical formula for pitavastatin is C50H46CaF2N2O8
and the molecular weight is 880.98. Pitavastatin is odorless and occurs as white
to pale-yellow powder. It is freely soluble in pyridine, chloroform, dilute
hydrochloric acid, and tetrahydrofuran, soluble in ethylene glycol, sparingly
soluble in octanol, slightly soluble in methanol, very slightly soluble in water
or ethanol, and practically insoluble in acetonitrile or diethyl ether. Pitavastatin
is hygroscopic and slightly unstable in light.
The chemical name for pitavastatin is (+)monocalcium bis{(3R, 5S, 6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate}.
The structural formula is:









Each film-coated tablet of LIVALO contains 1.045 mg, 2.09 mg, or 4.18 mg of pitavastatin calcium, which is equivalent to 1 mg, 2 mg, or 4 mg, respectively of free base and the following inactive ingredients: lactose monohydrate, low substituted hydroxypropylcellulose, hypromellose, magnesium aluminometasilicate, magnesium stearate, and film coating containing the following inactive ingredients: hypromellose, titanium dioxide, triethyl citrate, and colloidal anhydrous silica.Last reviewed on RxList: 9/15/2009





Other reviews about Livalo on wordpress

Statin Drugs | Side Effects
  by teamrich
Statin Drugs | Side Effects (stated by manufacturers) Tips on how you can find out what are the Side Effects of various Statin drugs on Users. Drug Packaging Materials Statin drug […]


Statins Update, Combos & CETP Inhibitors
  by extensointel
A recent update on statins combinations and CETP inhibitors Currently under development : Merck's CETP, Anacetrapib and Roche's Dalcetrapib Since the launch of Roches' s phase  III morbidity and mortality […]


Pitavastatin gains FDA approval
  by Larry Husten
The FDA today approved the 4 milligram maximum dose of Livalo (pitavastatin), a drug intended to improve blood cholesterol levels in persons with elevated or abnormal blood cholesterol […]


Another Cholesterol Drug to Join the U.S. Market
  by drugsinus
Who knew there would be another statin added to the crowded U.S. cholesterol-drug market? The FDA approved a new one yesterday. The medicine, known generically as pitavastatin, […]


Livalo Approved for High Cholesterol
  by timeinctemp
TUESDAY, Aug. 4 (HealthDay News) — Livalo (pitavastatin) is the newest statin to be approved by the U.S. Food and Drug Administration to treat high cholesterol. As with other […]


Kowa in publicity deal for tidings statin
  by doctorline
BOSTON, Dec 23 (Reuters) - Eli Lilly and Co (LLY.N) aforementioned on Wednesday it has incoming a co-promotion accord with privately held Kowa Co Ltd of Japan, in […]


CardioBriefs: Aggrenox study fails, Livalo launched, NY Times spotlights ICDs with benefits
  by Larry Husten
Aggrenox Fails to Beat Aspirin in Japanese Study: Aggrenox, the combination of extended-release dipyridamole and aspirin, is indicated for the reduction of subsequent stroke in patients who have […]


New Statin Holds Appeal for Untreated Patients (published in MM&M)
  by trevordeal
Kowa's US CEO says new statin holds appeal for untreated patients - Medical Marketing and Media. Congrats to Kowa and Lilly for this approval! Personally, I think it sounds […]


Livalo, the latest (Johnny Come Lately) Statin
  by docchat
The FDA has approved the marketing of Livalo, a statin, indicated for the treatment of high cholesterol. In addition to treating the usual, garden variety high cholesterol in […]



Other reviews about Livalo on web:

Learn about the prescription medication Livalo (Pitavastatin), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Livalo (Pitavastatin) Drug Information: Uses, Side Effects, Drug ...


LIVALO® is a fully synthetic and highly potent statin engineered in Japan. LIVALO® differs from other, currently available statins in the U.S. in that it has a unique cyclopropyl ... Kowa Pharmaceuticals America


Livalo (pitavastatin) is a new drug in development for the treatment of primary hyperlipidemia and mixed dyslipidemia. Livalo information includes news, clinical trial results and ... Kowa Announces NDA Submission and MAA Filing for HMG CoA Reductase ...


The FDA has approved Livalo (generic name: pitavastatin), a new cholesterol-lowering statin drug. Livalo already is sold in Japan, Korea, and Thailand. FDA Approves Livalo, a New Statin


Livalo (pitavastatin) is used to treat high cholesterol in adults (hypercholesterolemia). Includes Livalo side effects, interactions and indications. Livalo Information from Drugs.com


Read about cholesterol and related information. Learn how to lower your LDL cholesterol levels, and food and diet related to good cholesterol health. Livalo, a New Statin, Gets FDA Nod - Cholesterol Information ...


『リバロ錠 ~興和創薬株式会社 公式ホームページ~』 このサイトで弊社が提供する情報は弊社の医療用医薬品に関する情報を提供 ... LIVALO Worldwide


The U.S. Food and Drug Administration today approved the 4 milligram maximum dose of Livalo (pitavastatin), a drug intended to improve blood cholesterol levels in persons with ... FDA Approves New Cholesterol-Lowering Drug


Find lowest price for a Livalo prescription. Save up to 70% on drug prices at verified online pharmacies. Buy Livalo Online | Compare Livalo Prices & Save - Pharmahelper.com


LIVALO (pitavastatin) may have the potential for fewer drug-drug interactions, versus other statins, as evidenced by a new study that evaluated the effects of itraconazole, an ... Study Shows LIVALO(R) Is Not Affected By Co-Administration Of ...





Featured Reviews

Reviews Decadron

Decadron Drug Description DECADRON® (dexamethasone) Tablets, USP DRUG DESCRIPTION DECADRON* (dexamethasone tablets, USP) tablets, for oral administration, are supplied in two potencies, 0.5 mg and 0.75 mg. Inactive ingredients are...
Read More  |  Review This
Reviews Abciximab

ReoPro Drug Description REOPRO® (abciximab) For intravenous administration DRUG DESCRIPTION Abciximab, ReoProT, is the Fab fragment of the chimeric human-murine monoclonal antibody 7E3. Abciximab binds to the glycoprotein (GP)...
Read More  |  Review This
Reviews Synagis

Synagis Drug Description SYNAGIS® (palivizumab) DRUG DESCRIPTION What are the possible side effects of palivizumab (Synagis)? Get emergency medical help if your child has any of these signs of an allergic reaction: hives;...
Read More  |  Review This
Reviews Trospium Chloride Extended Release Capsule

Sanctura XR Drug Description SANCTURA XR™ (trospium chloride) Extended Release Capsules DRUG DESCRIPTION What are the possible side effects of trospium (Sanctura, Sanctura XR)? Get emergency medical help if you have any of...
Read More  |  Review This
Reviews Topotecan Capsules

Hycamtin Capsules Drug Description HYCAMTIN® (topotecan) Capsules WARNING BONE MARROW SUPPRESSION HYCAMTIN should be administered only to patients with baseline neutrophil counts of ≥ 1,500 cells/mm³ and a platelet count...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....